Our previous studies have shown that in non-small cell lung cancer and cervical cancer cell lines, EGF stimulation can promote intracellular Rab35 activity, thereby promoting tumor cell migration or proliferation (Duan et al., 2016; Zheng et al., 2017). This evidence concerns the gene EGF and non-small cell lung carcinoma.